Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Markus

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Stroke|March 1, 1997
Delayed improvement in carotid artery diameter after carotid angioplastyF Crawley, A Clifton, H Markus, et al.
British Journal of Clinical Pharmacology|July 17, 2004
In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemiaOlivier Kretz, H Markus Weiss, Martin M Schumacher, et al.
Biomedica Biochimica Acta|January 1, 1984
[Aortic baroreceptor function in narcotized rabbits during alpha-adrenoceptor blockade with prazosin]A Brattström, C Manutscharow, R Staak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2004
Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154Tappei Takada, H Markus Weiss, Olivier Kretz, et al.
Transplantation Proceedings|March 27, 2001
Daclizumab induction therapy in combination with tacrolimusB H Markus, S Weber, C Allers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognitionY L Colson, B H Markus, A Zeevi, et al.
Clinical and Experimental Immunology|August 1, 1989
Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayersY L Colson, B H Markus, A Zeevi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 6, 2008
Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical applicationH Markus Weiss, Marcel Fresneau, Thomas Moenius, et al.
Transplantation Proceedings|April 1, 1988
Interactions between endothelial cells and alloreactive T cells involved in allograft immunityY L Colson, B H Markus, A Zeevi, et al.
Der Anaesthesist|May 18, 2001
[Total endoscopic Nissen fundoplication with the robotic device "da Vinci" in children. Hemodynamics, gas exchange, and anesthetic management]D Meininger, C Byhahn, B H Markus, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Stroke|March 1, 1997
Delayed improvement in carotid artery diameter after carotid angioplastyF Crawley, A Clifton, H Markus, et al.
British Journal of Clinical Pharmacology|July 17, 2004
In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemiaOlivier Kretz, H Markus Weiss, Martin M Schumacher, et al.
Biomedica Biochimica Acta|January 1, 1984
[Aortic baroreceptor function in narcotized rabbits during alpha-adrenoceptor blockade with prazosin]A Brattström, C Manutscharow, R Staak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2004
Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154Tappei Takada, H Markus Weiss, Olivier Kretz, et al.
Transplantation Proceedings|March 27, 2001
Daclizumab induction therapy in combination with tacrolimusB H Markus, S Weber, C Allers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognitionY L Colson, B H Markus, A Zeevi, et al.
Clinical and Experimental Immunology|August 1, 1989
Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayersY L Colson, B H Markus, A Zeevi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 6, 2008
Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical applicationH Markus Weiss, Marcel Fresneau, Thomas Moenius, et al.
Transplantation Proceedings|April 1, 1988
Interactions between endothelial cells and alloreactive T cells involved in allograft immunityY L Colson, B H Markus, A Zeevi, et al.
Der Anaesthesist|May 18, 2001
[Total endoscopic Nissen fundoplication with the robotic device "da Vinci" in children. Hemodynamics, gas exchange, and anesthetic management]D Meininger, C Byhahn, B H Markus, et al.
Pageof 18